Anti-psychotic Medication Doubles the Risk of Life-Threatening Pneumonia

September 5, 2010 | Byron J. Richards, Board Certified Clinical Nutritionist

Send to a friend

* Required fields

  or  Cancel

 Anti-psychotic Medication Doubles the Risk of Life-Threatening Pneumonia
Anti-psychotic medications have taken over statins as the top-selling drug in America (2009 – 14.6 billion vs. 13.1 billion). Sales have been fueled by aggressive television marketing of the patent-protected anti-psychotics, while statin sales have declined due to generic drug competition. The anti-psychotic drugs make people obese and diabetic (as if we didn’t already have enough problems in those categories). They are often given to elderly and children as “behavior management” tools, a far cry from their approved use as a treatment for schizophrenia. A new study shows they double the risk for life-threatening pneumonia1 in the elderly.

Americans should be fed up with the crock that Big Pharma pushes down everyone’s throat. They specialize in “treatments” that the government/tax payers wind up paying for—as almost nobody would buy these drugs if they had to pay for them. The cost of these drugs ranges from $4,000 - $5,500 per year, depending on the drug. The use of anti-psychotic medication is bankrupting states through Medicaid obligations, and 99% of these drugs are for symptom-suppressing fraud.

Big Pharma and the doctors prescribing these medications are blatant enemies of the public health, and now we see that the anti-psychotic medications are a fast track to “pulling the plug on grandma.” The net result is making truly needed health care more expensive for everyone.

Referenced Studies

  1. ^ Pneumonia Risk and Antipsychotic Drug Use  Ann Intern Med April   Gianluca Trifirò, Giovanni Gambassi, Elif F. Sen, Achille P. Caputi, Vincenzo Bagnardi, Jose Brea, and Miriam C.J.M. Sturkenboom

Search thousands of health news articles!